Synthesis and pharmacological evaluation of fluorine-containing D₃ dopamine receptor ligands.
about
Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaineDopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.Synthesis and in vitro biological evaluation of carbonyl group-containing analogues for σ1 receptors.Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primate.Characterization of [(3) H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand.Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brain.Synthesis and in vitro pharmacological evaluation of indolyl carboxylic amide analogues as D3 dopamine receptor selective ligands.Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor.Ag-Catalyzed difluorohydration of β-alkynyl ketones for diastereoselective synthesis of 1,5-dicarbonyl compounds.Selectivity of probes for PET imaging of dopamine D3 receptors.Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions.
P2860
Q30424415-EF4FB2CE-9A84-4476-98A9-1B16C3CA731CQ33697312-F9E36CBF-B709-4ACF-8D4A-DDD762AACBB8Q35148443-BE5CFDEB-4F78-4597-95F2-A922A3DB2E2FQ35892818-A2F791C8-4891-4B9D-9291-11F3A8E9F7DAQ37252065-47827662-DEA8-47C9-A125-C0581E14EA70Q37568555-8B056C23-4770-4DBF-8A57-BED40607D795Q41993974-89458789-6569-4B28-9D21-6D248F8B79DEQ42035376-9D64C065-0AB4-4007-9F25-0321F990E6CFQ42940046-2F4DACB2-ACEE-474B-B47F-24AB44B285F7Q48149406-6A847978-9DDA-43BB-9BE0-619D53BA9F29Q48534307-288C2297-8225-42E2-A36C-31E2949C830FQ50201810-1CAB51A9-2C08-4ABB-B25E-1B573D396265Q52316241-1CEBDFF6-CD65-4F91-ADAA-878B016A8292Q54961225-2F4FB122-410B-4D43-A899-D23551D692D2
P2860
Synthesis and pharmacological evaluation of fluorine-containing D₃ dopamine receptor ligands.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Synthesis and pharmacological ...... D₃ dopamine receptor ligands.
@en
Synthesis and pharmacological ...... D₃ dopamine receptor ligands.
@nl
type
label
Synthesis and pharmacological ...... D₃ dopamine receptor ligands.
@en
Synthesis and pharmacological ...... D₃ dopamine receptor ligands.
@nl
prefLabel
Synthesis and pharmacological ...... D₃ dopamine receptor ligands.
@en
Synthesis and pharmacological ...... D₃ dopamine receptor ligands.
@nl
P2093
P2860
P356
P1476
Synthesis and pharmacological ...... g D₃ dopamine receptor ligands
@en
P2093
Michelle Taylor
Robert H Mach
Robert R Luedtke
Shihong Li
P2860
P304
P356
10.1021/JM101323B
P407
P577
2011-02-24T00:00:00Z